Clinical trial
Unfractionated Heparin in COVID-19 and Non-COVID-19 Patients - an Observational Study.
NCT05509647 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Unfractionated Heparin in COVID-19 and Non-COVID-19 Patients - an Observational Study.
- Lead sponsor
- Leiden University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2014
- Completion date
- October 1, 2022
- Enrollment
- 1,500 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, heparin overdose of undetermined intent